MORE►
Boehringer Ingelheim
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
by Dallas Innovates | Staff Report |
Nov 3, 2023
BioNTX, a leading nonprofit bioscience and healthcare innovation organization in North Texas, has appointed Jon Weidanz to its board of directors. Weidanz brings extensive experience as an immunology researcher, academic leader, biotech entrepreneur, and founder....
MORE►
by Alex Edwards |
Sep 27, 2021
Plus: Richardson's VOSS Solutions Lands $15M, Acquires Irving's LayerX
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
